Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London flag London · Delayed Price · Currency is GBP · Price in USD
546.04
-2.27 (-0.41%)
At close: Aug 1, 2025

United States Steel Statistics

Total Valuation

LON:0R2M has a market cap or net worth of GBP 43.75 billion. The enterprise value is 32.56 billion.

Market Cap43.75B
Enterprise Value 32.56B

Important Dates

The last earnings date was Friday, August 1, 2025.

Earnings Date Aug 1, 2025
Ex-Dividend Date May 20, 2025

Share Statistics

Current Share Class 101.87M
Shares Outstanding n/a
Shares Change (YoY) -1.73%
Shares Change (QoQ) -2.34%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 99.89M

Valuation Ratios

The trailing PE ratio is 13.44 and the forward PE ratio is 13.72.

PE Ratio 13.44
Forward PE 13.72
PS Ratio 4.22
PB Ratio 2.00
P/TBV Ratio 2.10
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 10.00
EV / Sales 3.03
EV / EBITDA 9.61
EV / EBIT 10.82
EV / FCF n/a

Financial Position

The company has a current ratio of 5.39, with a Debt / Equity ratio of 0.09.

Current Ratio 5.39
Quick Ratio 4.73
Debt / Equity 0.09
Debt / EBITDA 0.60
Debt / FCF n/a
Interest Coverage 108.92

Financial Efficiency

Return on equity (ROE) is 15.34% and return on invested capital (ROIC) is 7.84%.

Return on Equity (ROE) 15.34%
Return on Assets (ROA) 6.71%
Return on Invested Capital (ROIC) 7.84%
Return on Capital Employed (ROCE) 11.96%
Revenue Per Employee 684,453
Profits Per Employee 214,694
Employee Count15,106
Asset Turnover 0.38
Inventory Turnover 2.36

Taxes

In the past 12 months, LON:0R2M has paid 303.78 million in taxes.

Income Tax 303.78M
Effective Tax Rate 8.54%

Stock Price Statistics

The stock price has decreased by -47.75% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -47.75%
50-Day Moving Average 543.17
200-Day Moving Average 671.17
Relative Strength Index (RSI) 48.48
Average Volume (20 Days) 2,852

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, LON:0R2M had revenue of GBP 10.37 billion and earned 3.25 billion in profits. Earnings per share was 28.96.

Revenue10.37B
Gross Profit 5.13B
Operating Income 2.91B
Pretax Income 3.56B
Net Income 3.25B
EBITDA 3.28B
EBIT 2.91B
Earnings Per Share (EPS) 28.96
Full Income Statement

Balance Sheet

The company has 12.79 billion in cash and 1.97 billion in debt, giving a net cash position of 10.82 billion.

Cash & Cash Equivalents 12.79B
Total Debt 1.97B
Net Cash 10.82B
Net Cash Per Share n/a
Equity (Book Value) 21.85B
Book Value Per Share 207.92
Working Capital 15.66B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 49.47%, with operating and profit margins of 28.05% and 31.37%.

Gross Margin 49.47%
Operating Margin 28.05%
Pretax Margin 34.30%
Profit Margin 31.37%
EBITDA Margin 31.58%
EBIT Margin 28.05%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 1.35, which amounts to a dividend yield of 0.24%.

Dividend Per Share 1.35
Dividend Yield 0.24%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 1.73%
Shareholder Yield 1.97%
Earnings Yield 7.44%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2